An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

Study Identifier
S176.1.011
CT.gov Identifier
NCT01130298
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
    • Study Drug
  • Testosterone Gel 1.62%
    • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 80 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Inclusion Criteria * BMI between 20-35 kg/m\^2 inclusive. Exclusion Criteria * Males: history, current or suspected prostate or breast cancer. * Females: pregnant or lactating.

    Protocol Summary

    Single-center, single dose, open-label study in healthy male and female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.

    Study Locations

    No locations found.